Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Dried Blood Spot Thyroglobulin in Pregnant Women to Redefine the Range of Median Urinary Iodine Concentration That Indicates Adequate Iodine Intake

NCT03176706 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.

NCT NCT03176706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Dried Blood Spot Thyroglobulin in Pregnant Women to Redefine the Range of Median Urinary Iodine Concentration That Indicates Adequate Iodine Intake
Lead sponsor
Swiss Federal Institute of Technology
Phase
Observational
Overall status
Completed
Start date
August 9, 2017
Completion date
August 31, 2019
Enrollment
2,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

iodine deficiency, pregnancy related